Adviser
Lucid Capital Markets, LLC.
Fairness opinion, Financial adviser on 3 live deals, from 20 Aug 2025 to 3 Dec 2025. Also written as Lucid Capital Markets.
03Live deals
05Other advisers
Deals
| Date | Deal | Stage | Role | Sector |
|---|---|---|---|---|
| 3 Dec 2025 | Hyperliquid Strategies Inc / Sonnet BioTherapeutics Holdings, Inc. | Closed |
| Not stated |
| 10 Nov 2025 | Galecto, Inc. / Damora Therapeutics, Inc. | Closed |
| Healthcare |
| 20 Aug 2025 | XOMA Royalty Corporation / Mural Oncology plc | Agreement signed |
| Healthcare |
By year, sector and stage
| 2025 | 3 |
|---|
| Healthcare | 2 |
|---|---|
| Not stated | 1 |
| Closed | 2 |
|---|---|
| Agreement signed | 1 |
Other advisers on the same deals
| Adviser | Shared deals | Across the table | Alongside |
|---|---|---|---|
| Lucid | 2 | 0 | 2 |
| Gibson, Dunn & Crutcher LLP | 1 | 0 | 1 |
| Lowenstein Sandler LLP | 1 | 0 | 1 |
| Scheme Shareholders | 1 | 0 | 1 |
| Wedbush PacGrow | 1 | 0 | 1 |